<narrative xml:lang="en">Accelerating the fight against HIV, malaria and TB and strengthening health systems in Benin - Benin (01-Jan-2024-31-Dec-2026)</narrative>

47045-BEN-Z-CNLS-TP-1

The Global Fund to Fight AIDS, Tuberculosis and Malaria

<narrative xml:lang="en">Accelerating the fight against HIV, malaria and TB and strengthening health systems in Benin - Benin (01-Jan-2024-31-Dec-2026)</narrative> Benin, Multicomponent, Conseil National de Lutte contre le VIH/SIDA, la Tuberculose, le Paludisme, les Hépatites, les Infections sexuellement transmissibles et les Epidémies (CNLS-TP)This program has the following goals: Réduire de 50% d’ici 2026, les nouvelles infections liées aux pathologies prioritaires : VIH, tuberculose, paludisme, hépatites, IST, maladie à potentiel épidémique// By 2026, reduce by 50% new infections related to priority diseases: HIV, tuberculosis, malaria, hepatitis, STIs, diseases with epidemic potential. Réduire de 60% d’ici 2026, la mortalité et la morbidité liées aux pathologies prioritaires : VIH, tuberculose, paludisme, hépatites, IST et maladies à potentiel épidémique// By 2026, reduce mortality and morbidity related to priority diseases by 60% : HIV, tuberculosis, malaria, hepatitis, STIs and diseases with epidemic potential.. Assurer une gouvernance intégrée et performante de la riposte nationale aux pathologies prioritaires et aux maladies à potentiel épidémique // Ensure integrated and efficient governance of the national response to priority pathologies and diseases with epidemic potential. D’ici à 2030, réduire de 50% l’incidence du Paludisme et de 60% la mortalité liée au Paludisme par rapport à 2024 en éliminant les barrières liées aux groupes spécifiques / By 2030, reduce malaria incidence by 50% and malaria mortality by 60% compared with 2024, by eliminating barriers linked to specific groups.. The objectives of this program are: Le nombre de nouveaux cas de tuberculose toutes formes notifiées est augmenté de plus de 4,3% entre 2022 et 2026 (4111 en 2022 à 4285 en 2026)//The number of newly notified cases of TB increases by more 4,3% between 2022 and 2026(from 4111 in 2022 to 4285 in 2026).. Le taux de succès thérapeutique chez les nouveaux cas de tuberculose toutes formes et rechutes est maintenu à 90% en 2026// Percentage of all forms of TB cases (bacteriologically confirmed plus clinically diagnosed) successfully treated (cured plus treatment completed) among all forms of TB cases registered for treatment reaches 90% by 2026. Le taux de décès chez les patients Co-infectés TB/VIH est réduit à au plus 9% en 2026 // The mortality rate among co-infected TB/HIV patients is reduced to less than 9% by 2026. Au moins 82% des malades multi-résistants mis sous traitement de 2ème ligne sont des succès thérapeutiques en 2026 // At least 82% of patients with MDR-TB who are on treatment therapeutic successes, by 2026. Renforcer la gestion du programme à tous les niveaux pour atteindre efficacement les objectifs du plan stratégique // Strengthen program management at all levels to effectively achieve strategic plan objectives. Tester 100 % des cas suspects de paludisme et traiter 100 % des cas confirmés de paludisme dans les établissements de santé publics, privés et au niveau communautaire, conformément aux directives nationales // Test 100% of suspected malaria cases and treat 100% of confirmed malaria cases in public, private and community health facilities, in accordance with national guidelines.. Assurer une couverture d'au moins 95 % de la population ciblée avec toutes les interventions de prévention pertinentes // Ensure coverage of at least 95% of the target population with all relevant prevention interventions. Renforcer le système de surveillance afin que 100 % des données relatives au paludisme attendues soient rapportées à temps et de bonne qualité et qu'elles soient utilisées pour suivre et évaluer le programme de lutte antipaludique / Strengthen the surveillance system so that 100% of expected malaria data are reported on time and in good quality, and are used to monitor and evaluate the malaria control program.. D'ici 2030, 90% des personnes recherchent des soins de santé appropriés et utilisent une méthode de protection appropriée / By 2030, 90% of people seek appropriate health care and use an appropriate method of protection. D’ici à 2030, réduire d’au moins 70% les écarts dans l’accès a la prévention et la prise en charge du paludisme au sein des groupes les plus exclus des services sociaux de base / By 2030, reduce by at least 70% the gaps in access to malaria prevention and treatment among the groups most excluded from basic social services.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

Conseil National de Lutte contre le VIH/SIDA, la Tuberculose, le Paludisme, les Hépatites, les Infections sexuellement transmissibles et les Epidémies

The Global Fund to Fight AIDS, Tuberculosis and Malaria

The Global Fund to Fight AIDS Tuberculosis and Malaria Communications

Web Team

+41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org

The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland

The Global Fund to Fight AIDS Tuberculosis and Malaria Grant Management Division

Plaikessi, KOUADJANI

Fund Portfolio Manager

+41 58 791 1700 plaikessi.kouadjani@theglobalfund.org https://www.theglobalfund.org

The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland

The Global Fund to Fight AIDS Tuberculosis and Malaria Communications

Web Team

+41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org

The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland

Benin

HIV Malaria Multicomponent RSSH Tuberculosis

HIV -> Differentiated HIV Testing Services -> Community-based testing for AGYW and their male sexual partners programs

HIV -> Differentiated HIV Testing Services -> Community-based testing for KP programs

HIV -> Differentiated HIV Testing Services -> Community-based testing outside of KP and AGYW programs

HIV -> Differentiated HIV Testing Services -> Facility-based testing for adolescent girls and young women (AGYW) and their male sexual partners programs

HIV -> Differentiated HIV Testing Services -> Facility-based testing for key population (KP) programs

HIV -> Differentiated HIV Testing Services -> Facility-based testing outside of key population (KP) and adolescent girls and young women (AGYW) programs

HIV -> Differentiated HIV Testing Services -> Self-testing for AGYW and their male sexual partners programs

HIV -> Differentiated HIV Testing Services -> Self-testing for KP programs

HIV -> Differentiated HIV Testing Services -> Self-testing outside of KP and AGYW programs

HIV -> Elimination of vertical transmission of HIV, syphilis and hepatitis B -> Early infant diagnosis and follow-up HIV testing for exposed infants

HIV -> Elimination of vertical transmission of HIV, syphilis and hepatitis B -> Integrated testing of pregnant women for HIV, syphilis and hepatitis B

HIV -> Elimination of vertical transmission of HIV, syphilis and hepatitis B -> Post-natal infant prophylaxis

HIV -> Elimination of vertical transmission of HIV, syphilis and hepatitis B -> Retention support for pregnant and breastfeeding women (facility and community)

HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> Condom and lubricant programing for MSM

HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> Pre-exposure prophylaxis (PrEP) programing for MSM

HIV -> Prevention package for other vulnerable populations (OVP) -> Condom and lubricant programing for OVP

HIV -> Prevention package for other vulnerable populations (OVP) -> HIV prevention communication, information and demand creation for OVP

HIV -> Prevention package for other vulnerable populations (OVP) -> Pre-exposure prophylaxis (PrEP) programing for OVP

HIV -> Prevention package for people in prisons and other closed settings -> HIV prevention communication, information and demand creation for prisoners

HIV -> Prevention package for people in prisons and other closed settings -> Removing human rights-related barriers to prevention for prisoners

HIV -> Prevention package for people in prisons and other closed settings -> Sexual and reproductive health services, including STIs, hepatitis, post-violence care for prisoners

HIV -> Prevention package for people who use drugs (PUD) and their sexual partners -> Condom and lubricant programing for PUD

HIV -> Prevention package for people who use drugs (PUD) and their sexual partners -> Needle and syringe programs for PWID

HIV -> Prevention package for people who use drugs (PUD) and their sexual partners -> Opioid substitution therapy and other medically assisted drug dependence treatment for PWID

HIV -> Prevention package for sex workers, their clients and other sexual partners -> Community empowerment for sex workers

HIV -> Prevention package for sex workers, their clients and other sexual partners -> Condom and lubricant programing for sex workers

HIV -> Prevention package for sex workers, their clients and other sexual partners -> HIV prevention communication, information and demand creation for sex workers

HIV -> Prevention package for sex workers, their clients and other sexual partners -> Pre-exposure prophylaxis (PrEP) programing for sex workers

HIV -> Prevention package for sex workers, their clients and other sexual partners -> Sexual and reproductive health services, including STIs, hepatitis, post-violence care for sex workers

HIV -> Prevention package for transgender people and their sexual partners -> Condom and lubricant programing for transgender people

HIV -> Treatment, care and support -> Diagnosis and management of advanced disease (adults and children)

HIV -> Treatment, care and support -> HIV treatment and differentiated service delivery - adults (15 and above)

HIV -> Treatment, care and support -> HIV treatment and differentiated service delivery - children (under 15)

HIV -> Treatment, care and support -> Integrated management of common co-infections and co-morbidities (adults and children)

HIV -> Treatment, care and support -> Treatment monitoring - Viral load and antiretroviral (ARV) toxicity

Malaria -> Case management -> Facility-based treatment

Malaria -> Case management -> HRP2/3 gene deletion surveys

Malaria -> Case management -> Integrated community case management (iCCM)

Malaria -> Case management -> Private sector case management

Malaria -> Specific prevention interventions (SPI) -> Intermittent preventive treatment (IPT) - In pregnancy

Malaria -> Specific prevention interventions (SPI) -> Removing human rights and gender-related barriers to specific prevention interventions

Malaria -> Specific prevention interventions (SPI) -> Seasonal malaria chemoprevention

Malaria -> Specific prevention interventions (SPI) -> Social and behavior change (SBC) (SPI)

Malaria -> Vector control -> Entomological monitoring

Malaria -> Vector control -> Insecticide treated nets (ITNs) - Continuous distribution: ANC

Malaria -> Vector control -> Insecticide treated nets (ITNs) - Continuous distribution: EPI

Malaria -> Vector control -> Insecticide treated nets (ITNs) - Continuous distribution: school based

Malaria -> Vector control -> Insecticide treated nets (ITNs) - Mass campaign: universal

Malaria -> Vector control -> Social and behavior change (SBC) (Vector control)

Multicomponent -> Program management -> Coordination and management of national disease control programs

Multicomponent -> Program management -> Grant management

RSSH -> RSSH: Health financing systems -> Health financing strategies and planning

RSSH -> RSSH: Health financing systems -> Public financial management (PFM) systems

RSSH -> RSSH: Health financing systems -> Routine financial management systems

RSSH -> RSSH: Health products management systems -> Planning and procurement capacity

RSSH -> RSSH: Health products management systems -> Regulatory/quality assurance support

RSSH -> RSSH: Health products management systems -> Storage and distribution capacity, design & operations

RSSH -> RSSH: Health products management systems -> Supply chain information systems

RSSH -> RSSH: Health sector planning and governance for integrated people-centered services -> National health sector strategy, policy & regulations

RSSH -> RSSH: Monitoring and evaluation systems -> Analyses, evaluations, reviews and data use

RSSH -> RSSH: Monitoring and evaluation systems -> Data quality

RSSH -> RSSH: Monitoring and evaluation systems -> Operational Research

RSSH -> RSSH: Monitoring and evaluation systems -> Routine reporting

RSSH -> RSSH: Monitoring and evaluation systems -> Surveillance for HIV, tuberculosis and malaria

RSSH -> RSSH: Monitoring and evaluation systems -> Surveys

RSSH -> RSSH/PP: Human resources for health (HRH) and quality of care -> RSSH/PP: Community health workers: contracting, remuneration and retention

RSSH -> RSSH/PP: Human resources for health (HRH) and quality of care -> RSSH/PP: Community health workers: In-service training

RSSH -> RSSH/PP: Human resources for health (HRH) and quality of care -> RSSH/PP: Integrated supportive supervision for health workers (excluding CHWs)

RSSH -> RSSH/PP: Human resources for health (HRH) and quality of care -> RSSH/PP: Quality improvement and capacity building for quality of care

RSSH -> RSSH/PP: Human resources for health (HRH) and quality of care -> RSSH/PP: Remuneration and deployment of existing/new staff (excluding community health workers)

RSSH -> RSSH/PP: Laboratory systems (including national and peripheral) -> RSSH/PP: Biosafety and biosecurity, infrastructure and equipment

RSSH -> RSSH/PP: Laboratory systems (including national and peripheral) -> RSSH/PP: Laboratory Information systems

RSSH -> RSSH/PP: Laboratory systems (including national and peripheral) -> RSSH/PP: Laboratory supply chain systems

RSSH -> RSSH/PP: Laboratory systems (including national and peripheral) -> RSSH/PP: Quality management systems and accreditation

RSSH -> RSSH/PP: Laboratory systems (including national and peripheral) -> RSSH/PP: Specimen referral and transport system

Tuberculosis -> Collaboration with other providers and sectors -> Community-based TB/DR-TB care

Tuberculosis -> Drug-resistant (DR)-TB diagnosis, treatment and care -> DR-TB diagnosis/drug susceptibility testing (DST)

Tuberculosis -> Drug-resistant (DR)-TB diagnosis, treatment and care -> DR-TB treatment, care and support

Tuberculosis -> Key and vulnerable populations (KVP) - TB/DR-TB -> KVP - Children and adolescents

Tuberculosis -> Key and vulnerable populations (KVP) - TB/DR-TB -> KVP - People in prisons/jails/detention centers

Tuberculosis -> Removing human rights and gender related barriers to TB services -> Eliminating TB-related stigma and discrimination

Tuberculosis -> TB diagnosis, treatment and care -> TB screening and diagnosis

Tuberculosis -> TB diagnosis, treatment and care -> TB treatment, care and support

Tuberculosis -> TB/DR-TB Prevention -> Infection prevention and control (IPC)

Tuberculosis -> TB/DR-TB Prevention -> Preventive treatment

Tuberculosis -> TB/DR-TB Prevention -> Screening/testing for TB infection

Tuberculosis -> TB/HIV -> TB/HIV - Collaborative interventions

Tuberculosis -> TB/HIV -> TB/HIV - Prevention

Tuberculosis -> TB/HIV -> TB/HIV - Screening, testing and diagnosis

Tuberculosis -> TB/HIV -> TB/HIV - Treatment and care

46839969.00

28971394.29

9390002.94

234329.13 Global Fund Commitment to BEN-Z-CNLS-TPP01.

Global Fund to Fight AIDS, Tuberculosis and Malaria